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Dear Editor, 
The  risk  of  transfusion-transmitted  hepatitis  C  virus 
(HCV) infection was the greatest in people with hae-
mophilia (PWH) before identification and testing for 
this virus became available in 1987.  After introduction 
of HCV screening and virucidal measures post 1987, 
this risk significantly reduced in the developed coun-
tries (1.8%).
1 However, in resource poor settings, the 
risk still remained high. The HCV seroprevalence rate 
among PWH in Brazil was as high at 44%,
2 with that 
in Pakistan higher at 56%.
3 
In the haemophilia population, diagnosis of HCV 
appears to be earlier (29-31 years),
4 compared to oth-
er  non-hemophilia  patient  populations  (52  years).
5 
This difference could be due to a number of reasons, 
chronicity of hemophilia and close clinical follow of 
PWH by dedicated teams being some of the contrib-
uting factors. Knowledge on HCV genotypes and vi-
ral loads are important in making treatment decisions 
as well as predicting response to treatment. From a 
public health perspective, knowledge of the genotype 
frequencies and their changes can provide important 
epidemiological  information  for  screening  and  pre-
ventative  public  programs.
6  HCV  genotyping  tests 
have  transformed  over  the  years  from  in-house  se-
quencing to commercialised line probe assays (LiPA) 
and as well as real-time PCR analyses. However, the 
method of choice should be sensitive enough to detect 
all HCV genotypes including mixed genotype infec-
tions. Although earlier reports seem to indicate that 
mixed  genotype  infections  were  rare,
7  recent  data 
indicate that the diagnosis of mixed genotypes has 
been increasing as indicated by Alavian et al.,
8 (4%; 
1 and 3, 3 and 4) and Oh et al.,
9 (4.4%, genotype 1b 
and 2a/c). This is largely as a result of evolution of 
more  sensitive  HCV  genotyping  assays.  Conse-
quently, the apparent discrepancy between the mixed 
genotype rates reported by the two studies done in 
Iran at different time frames rate 6.2%
4 and 27%
10 
that could be ascribed in part to the availability of 
more sensitive methods.  
Efforts  to  start  and  continue  the  diagnosis  and 
treatment of HCV in sentinel groups are needed to 
reduce transmission of the virus and the future burden 
of chronic liver diseases. The cost of sensitive and 
specific PCR and genotyping methods is daunting for 
countries  with  limited  resources.  However,  surveil-
lance systems and notification to government is re-
quired so that awareness is raised and proper action 
taken. Public education campaigns like the “start to-
day, tomorrow may be late”
4 and “Be Blood Aware”
1 
are good role models to follow. Although total popu-
lation of PWH screened by Keshvari and colleagues 
(2010) represent less that 10% of the total hemophilia 
population in Iran,
4 this effort is to be applauded as it 
signals a step in the right direction to total manage-
ment of HCV in PWH. 
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